Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis
What this study shows
Rapamycin given before resistance exercise blocked the early (1–2 h) post-exercise rise in human muscle protein synthesis, which was about 40% in the control group. Rapamycin also blocked the rise in ERK1/2 phosphorylation and blunted MNK1, so the authors conclude that mTORC1 drives the response only in part. The study measured acute protein synthesis, not muscle growth.
At a glance
| Evidence type | H Human study Marked H because it is direct evidence from a human clinical trial or human cohort; the code names the kind of study, not its quality -- a small, well-run trial is still H. |
| Study type | 2 - Human Clinical Trial |
| Model system | Humans, controlled trial |
| Journal | Journal of Physiology |
| Year | 2009 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1113/jphysiol.2008.163816 · PMID 19188252 · Free full text (PMC2678224) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Rapamycin (pre-exercise) |
| Target | mTORC1 |
| Model | Human – controlled trial |
| Effect | Rapamycin blocks the contraction-induced increase in human skeletal muscle protein synthesis |
| Dose | Rapamycin, single oral dose before a bout of high-intensity resistance exercise (exact mg not captured; full text not retrievable via PMC). |
| Sample size | Small human controlled trial (full text unavailable; abstract-level). |
| Effect size | Rapamycin blocked the early (1-2 h) ~40% contraction-induced increase in human muscle protein synthesis; downstream mTORC1 signaling (S6K1) blunted. |
| Limitations | Small sample; full text not retrievable via PMC, so dose/n taken from abstract only. |
In the Atlas
Related topics
Links in the pathway map
Open questions that cite this study
- Cited as supporting evidence for the open question Muscle-sparing, pulsed mTORC1 inhibition.
More studies on this topic
- Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo (2001)
- Feeding-Induced Muscle mTORC1 Signaling Regulates Postprandial Protein Synthesis and Endurance but Not Muscle Size (2026)
- D-Amino Acid Prodrug DLMEH Activates mTORC1 via Sestrin2 to Restore Muscle Protein Synthesis in Sarcopenia. (2026)
- Strengthening Muscle for Healthy Ageing: Innovative Treatments for Sarcopenia (2026)
Was this page useful?
Thank you. Your answer was counted anonymously.